Earnings Date
Nov 1
EPS
$-0.550
Quarterly Revenue
$11.1M
Annual Revenue (as of Sep 30)
$20.3M
Earnings History
Analyze the earnings history of C4 Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/22/2024 | AM | CCCC | Q4 | -$0.76 | — | — | — | $2.85M | — | — | — | Get Alert |
| 11/01/2023 | AM | CCCC | Q3 | -$0.65 | -$0.66 | -$0.55 | 16.67% | $6.75M | $5.46M | $11.07M | 102.78% | Get Alert |
| 08/08/2023 | AM | CCCC | Q2 | -$0.56 | -$0.69 | -$0.73 | -5.80% | $13.83M | $6.44M | $2.66M | -58.63% | Get Alert |
| 05/04/2023 | AM | CCCC | Q1 | -$0.65 | -$0.75 | -$0.71 | 5.33% | $7.65M | $5.46M | $3.76M | -31.15% | Get Alert |
| 02/23/2023 | AM | CCCC | Q4 | -$0.31 | -$0.74 | -$0.76 | -2.70% | $20.09M | $7.81M | $2.85M | -63.46% | Get Alert |
| 11/03/2022 | AM | CCCC | Q3 | -$0.51 | -$0.67 | -$0.65 | 2.99% | $8.50M | $9.07M | $6.75M | -25.53% | Get Alert |
| 08/04/2022 | AM | CCCC | Q2 | -$0.51 | -$0.69 | -$0.56 | 18.84% | $9.78M | $7.64M | $13.83M | 81.07% | Get Alert |
| 05/05/2022 | AM | CCCC | Q1 | -$0.49 | -$0.58 | -$0.65 | -12.07% | $7.43M | $8.05M | $7.65M | -4.92% | Get Alert |
| 02/24/2022 | AM | CCCC | Q4 | -$3.45 | -$0.58 | -$0.31 | 46.55% | $8.26M | $7.08M | $20.09M | 183.80% | Get Alert |
| 11/10/2021 | PM | CCCC | Q3 | -$17.55 | -$0.59 | -$0.51 | 13.56% | $8.45M | $7.61M | $8.50M | 11.70% | Get Alert |
| 08/11/2021 | PM | CCCC | Q2 | — | -$0.59 | -$0.51 | 13.56% | — | $6.02M | $9.78M | 62.48% | Get Alert |
| 05/13/2021 | PM | CCCC | Q1 | — | -$0.69 | -$0.49 | 28.99% | $6.80M | — | $7.43M | — | Get Alert |
| 03/11/2021 | PM | CCCC | Q4 | — | — | -$3.45 | — | — | — | $8.26M | — | Get Alert |
| 11/12/2020 | PM | CCCC | Q3 | -$8.93 | — | -$17.55 | — | $5.36M | — | $8.45M | — | Get Alert |
When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?
C4 Therapeutics (CCCC) is scheduled to report earnings on February 22, 2024. The last reported earnings were for reported on November 1, 2023 for Q3.
What were the latest earnings per share (EPS) for C4 Therapeutics (NASDAQ:CCCC)?
The Actual EPS was $-0.55, which beat the estimate of $-0.66.
What were C4 Therapeutics’s (NASDAQ:CCCC) revenues?
The Actual Revenue was $11.1M, which beat the estimate of $5.5M.
Browse earnings estimates, EPS, and revenue on all stocks.